-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection
Christoph Honer zu Siederdisse & Markus Cornberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Review: Clinical Trail Outcomes: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation